Literature DB >> 16634640

r-VKORC1 expression in factor IX BHK cells increases the extent of factor IX carboxylation but is limited by saturation of another carboxylation component or by a shift in the rate-limiting step.

Kevin W Hallgren1, Wen Qian, Anna V Yakubenko, Kurt W Runge, Kathleen L Berkner.   

Abstract

Carboxylation of vitamin K-dependent (VKD) proteins is required for their activity and depends on reduced vitamin K generated by vitamin K oxidoreductase (VKOR) and a redox protein that regenerates VKOR activity. VKD protein carboxylation is inefficient in mammalian cells, and to understand why carboxylation becomes saturated, we developed an approach that directly measures the extent of intracellular VKD protein carboxylation. Analysis of factor IX (fIX)-expressing BHK cells indicated that slow egress of fIX from the endoplasmic reticulum and preferential secretion of the carboxylated form contribute to secreted fIX being more fully carboxylated. The analysis also revealed the first reported in vivo VKD protein turnover, which was 14-fold faster than that which occurs in vitro, suggesting facilitation of this process in vivo. r-VKORC1 expression increased the rate of fIX carboxylation and the extent of secreted carboxylated fIX approximately 2-fold, which shows that carboxylation is the rate-limiting step in fIX turnover and which was surprising because turnover in vitro is limited by release of carboxylated fIX. Interestingly, the increases were significantly smaller than the amount of VKOR overexpression (15-fold). However, when cell extracts were tested in single-turnover experiments in vitro, where redox protein is functionally substituted with dithiothreitol, VKOR overexpression increased the fIX carboxylation rate 14-fold, showing r-VKORC1 is functional for supporting fIX carboxylation. These data indicate that the effect of VKOR overexpression is limited in vivo, possibly because a carboxylation component like the redox protein becomes saturated or because another step is now rate-limiting. The studies illustrate the complexity of carboxylation and potential importance of component stoichiometry to overall efficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16634640      PMCID: PMC2512261          DOI: 10.1021/bi051986y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  41 in total

1.  Purification and characterization of dicoumarol-induced prothrombins. II. Barium oxalate atypical (5-Gla) variant.

Authors:  O P Malhotra
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

2.  Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells.

Authors:  R J Kaufman; L C Wasley; B C Furie; B Furie; C B Shoemaker
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

3.  Report of Workshop on expression of vitamin K-dependent proteins in bacterial and mammalian cells, Madison, Wisconsin, USA, April 1986.

Authors:  J W Suttie
Journal:  Thromb Res       Date:  1986-10-01       Impact factor: 3.944

4.  Expression of recombinant vitamin K-dependent proteins in mammalian cells: factors IX and VII.

Authors:  K L Berkner
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

5.  Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition.

Authors:  D S Whitlon; J A Sadowski; J W Suttie
Journal:  Biochemistry       Date:  1978-04-18       Impact factor: 3.162

6.  Vitamin K-dependent carboxylase. Requirements of the rat liver microsomal enzyme system.

Authors:  J A Sadowski; C T Esmon; J W Suttie
Journal:  J Biol Chem       Date:  1976-05-10       Impact factor: 5.157

7.  Endoproteolytic processing of the human protein C precursor by the yeast Kex2 endopeptidase coexpressed in mammalian cells.

Authors:  D C Foster; R D Holly; C A Sprecher; K M Walker; A A Kumar
Journal:  Biochemistry       Date:  1991-01-15       Impact factor: 3.162

8.  Vitamin K counteracts the effect of warfarin in liver but not in bone.

Authors:  P A Price; Y Kaneda
Journal:  Thromb Res       Date:  1987-04-01       Impact factor: 3.944

9.  In vitro and in vivo functional characterization of bovine vitamin K-dependent gamma-carboxylase expressed in Chinese hamster ovary cells.

Authors:  A Rehemtulla; D A Roth; L C Wasley; A Kuliopulos; C T Walsh; B Furie; B C Furie; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

10.  Expression of recombinant human plasminogen in mammalian cells is augmented by suppression of plasmin activity.

Authors:  S J Busby; E Mulvihill; D Rao; A A Kumar; P Lioubin; M Heipel; C Sprecher; L Halfpap; D Prunkard; J Gambee
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

View more
  16 in total

1.  siRNA silencing of calumenin enhances functional factor IX production.

Authors:  Nadeem Wajih; Susan M Hutson; Reidar Wallin
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

2.  Compound heterozygosity of novel missense mutations in the gamma-glutamyl-carboxylase gene causes hereditary combined vitamin K-dependent coagulation factor deficiency.

Authors:  Dhouha Darghouth; Kevin W Hallgren; Rebecca L Shtofman; Amel Mrad; Youssef Gharbi; Ahmed Maherzi; Radhia Kastally; Sophie LeRicousse; Kathleen L Berkner; Jean-Philippe Rosa
Journal:  Blood       Date:  2006-05-23       Impact factor: 22.113

3.  Novel insight into the mechanism of the vitamin K oxidoreductase (VKOR): electron relay through Cys43 and Cys51 reduces VKOR to allow vitamin K reduction and facilitation of vitamin K-dependent protein carboxylation.

Authors:  Mark A Rishavy; Aisulu Usubalieva; Kevin W Hallgren; Kathleen L Berkner
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

4.  Enhanced functional recombinant factor VII production by HEK 293 cells stably transfected with VKORC1 where the gamma-carboxylase inhibitor calumenin is stably suppressed by shRNA transfection.

Authors:  Nadeem Wajih; John Owen; Reidar Wallin
Journal:  Thromb Res       Date:  2008-01-03       Impact factor: 3.944

5.  Functional Study of the Vitamin K Cycle Enzymes in Live Cells.

Authors:  J-K Tie; D W Stafford
Journal:  Methods Enzymol       Date:  2016-11-22       Impact factor: 1.600

6.  Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase.

Authors:  Mark A Rishavy; Kevin W Hallgren; Lee Wilson; Savita Singh; Kurt W Runge; Kathleen L Berkner
Journal:  Blood       Date:  2018-03-28       Impact factor: 22.113

Review 7.  Vitamin K oxygenation, glutamate carboxylation, and processivity: defining the three critical facets of catalysis by the vitamin K-dependent carboxylase.

Authors:  Mark A Rishavy; Kathleen L Berkner
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

8.  The vitamin K oxidoreductase is a multimer that efficiently reduces vitamin K epoxide to hydroquinone to allow vitamin K-dependent protein carboxylation.

Authors:  Mark A Rishavy; Kevin W Hallgren; Lee A Wilson; Aisulu Usubalieva; Kurt W Runge; Kathleen L Berkner
Journal:  J Biol Chem       Date:  2013-08-05       Impact factor: 5.157

9.  Gla-rich protein (GRP), a new vitamin K-dependent protein identified from sturgeon cartilage and highly conserved in vertebrates.

Authors:  Carla S B Viegas; Dina C Simes; Vincent Laizé; Matthew K Williamson; Paul A Price; M Leonor Cancela
Journal:  J Biol Chem       Date:  2008-10-03       Impact factor: 5.157

10.  VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites.

Authors:  Katrin J Czogalla; Kerstin Liphardt; Klara Höning; Veit Hornung; Arijit Biswas; Matthias Watzka; Johannes Oldenburg
Journal:  Blood Adv       Date:  2018-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.